Atrial natriuretic factor and mitral valve prolapse syndrome

Minerva Cardioangiologica

Volumn 49, Issue 5, 2001, Pages 317-325

  Di Salvo, G ^a,b   Pergola, V ^a   Ratti, G ^a   Tedesco, M A ^a   Giordano, C ^a   Scialdone, A ^a   Iacono, A ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b NONE   (Italy)

Author keywords

Atrial natriuretic factor; Mitral valve prolapse, etiology; Neurosecretory system

Indexed keywords

ATRIAL NATRIURETIC FACTOR;

BLOOD; HUMAN; MITRAL VALVE PROLAPSE; PHYSIOLOGY; REVIEW;

ATRIAL NATRIURETIC FACTOR; HUMANS; MITRAL VALVE PROLAPSE;

EID: 0035491555     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Kimura J, Scott R, Willis CL, DeMaria AN. Accuracy and cost-effectiveness of single view echocardiographic screening for suspected mitral valve prolapse. Am J Medicine 2000;138:331-6.
2. Procacci FM, Sauran SV, Schreiter SL, Garyson AL. Prevalence of clinical mitral valve prolapse in 1,169 young women. N Engl J Med 1976;294:1086-8.
3. Mlarkiewicz W, Stoner I, London E et al. Mitral valve prolapse in one hundred presumably healthy young females. Circulation 1976;55:464-7.
4. Jeresaty RM. Mitral valve prolapse. New York: Raven Press, 1979:4-19.
5. Boudoulas H, King BD, Wooley CF. Mitral valve prolapse: A marker for anxiety or overlapping phenomenon? Psychopathol 1984;17(Suppl. 1):98-106.
6. Boudoulas H, Wooley CF. Mitral valve prolapse and the mitral valve prolapse syndrome. Mount Kisco, New York: Futura Publishing Company Inc. 1988:161-7.
7. Boudoulas H, Kohbash AI, Baker P, King BD, Wolley CF. Mitral valve prolapse and the mitral valve prolapse syndrome: a diagnostic classification and pathogenesis of symptoms. Am Heart J 1989;118:796-818.
8. Boudoulas H, Reynolds JC, Mazzaferri E, Wooley CF. Metabolic studies in mitral valve prolapse syndrome. Circulation 1980;61:1200-5.
9. Grigioni F, Sarano ME, Ling LH, Bailey KR, Seward JB, Tajik J et al. Sudden death in mitral regurgitation due to flail leaflet. J Am Coll Cardiol 1999;34:2072-85.
10. Gaffney AF, Blomqvist GC. Mitral valve prolapse and autonomic nervous system dysfunction: a pathophisyological link. In: Boudoulas T, Wooley CF, editors. Mitral valve prolapse syndrome. Mount Kisco, NY: Futura Publishing Company, INK, 1988:427-45.
11. Davies AO, Mares A, Pool JL, Taylor AA. Mitral valve prolapse with symptoms of beta adrenergic hypersensitivity Beta 2 adrenergic receptor supercoupling with desensitization of isoproterenol exposure. Am J Med 1987;82:195-201.
12. Zdrojewski TR, Wyrzykowski S, KrupaWojciechowska B. Renin Aldosterone regulation during upright posture in young men with ml. VP J Heart Valve Dis 1995;4:236-41.
13. Gaffney AF, Bastian BC, Lane LB, Taylor FW, Horton J, Shutte JE et al. Abnormal cardiovascular regulation in the mitral valve prolapse. Am J Cardiol 1985;52:516-20.
14. Coghlan HC, Phares P, Crowley M, Copley D, James TN. Dysautonomia in mitral valve prolapse. Am J Med 1979; 67:236-44.
15. Pastemac A, Kouz S, Gutkowska J, Petitclerc R, Taillefer R, Cequier A et al. Atrial natriuretic factor: a possible link between left atrium, plasma volume, adrenergic control and renin aldosterone in mitral valve prolapse syndrome. J Hypertens 1986;4:76-9.
16. Rogers JM, Boudoulas H, Wooley CF. Abnormal reninaldosteron response to volume depletion in mitral valve prolapse (Abstract). Circulation 1984;70(Suppl. II):556-8.
17. Bashore TM, Urines C, Utlak D, Boudoulas H, Wooley CF. Postural exercise abnormalities in symptomatic patients with mitral valve prolapse. J Am Coll Cardiol 1988;11:499-507.
18. Boudoulas H, Wooley CF. Hyperadrenergic state, autonomic dysfunction, and pathogenesis of symptoms in mitral valve prolapse syndrome. In: Boudoulas H, Wooley CF, editors. Mitral valve prolapse and mitral valve prolapse syndrome. Mount Kisco NY: Futura Publishing Company Inc, 1988:479-81.
19. Cantin M, Genest J. The heart and the atrial natriuretic facton Endocr Rev 1985;6:107-27.
20. Brenner BM, Ballerman BJ, Gunning ME, Zeidel ML. Diverse biological actions of atrial natriuretic peptide. Physiol Rev 1990;70:665-9.
21. Cogan MG. Atrial natriuretic peptide. Kid int 1990;57: 1148-60.
22. Goetz KL. Phiysiology and physiopatology of atrial peptides. Am J Physiol 1988;254:1-15.
23. Laragh JH. The endocrine control of the blood volume, blood pressure and sodium balance: Atrial hormone and renin system interactions. J Hypertension 1986;4(Suppl. 2):5145-56.
24. Baines AD, de Bold AJ, Sonnenberg H. Natriuretic effect of atrial extract on isolated perfused rat kidney. Can J Physiol Pharmacol 1985;61:1462-6.
25. Cogan MU. Renal effects of atrial nariuretic factor. Ann Rev Physiol 1990;52:699-708.
26. Baesley D, Malvin RL. Atrial extacts increase glomerular ultration rate in vivo. Am J Physiol 1985;248:24-30.
27. Pollock DM, Arendshorst WJ. Effects of artial natriuretic factor on renal hemodynamics in the rat. Am J Physiol 1986;251:795-801.
28. Maack T, Atlas SA, Camargo MJF. Renal hemodynamic and natriuretic effects of atrial natriuretic factor. Fed Proc 1986;45:2128-52.
29. Pomeranz A, Podjarny J, Rathaus M. Atrial natriuretic peptide induced increase of glomerular filtration rate, but not of natriuresis, is metiated by prostaglandins in the rat. Miner Electrolyte Metab 1990;16:50-5.
30. Obana K, Naruse M, Sakurai H. Synthetic atrial natriuretic factor inhibits in vitro and in vivo renin secrection in rats. Endocrinol 1985;17:1282-4.
31. Kurtz A, Della Bruna R, Bauer C. Effect of synthetic atrial natriuretic factor on rat renal juxtaglomerular cells. J Hypertens 1986;4:557-60.
32. Henrich WL, McAllister EA. Direct inhibitory effect of atriopeptin III on renin release in primate kidney. Life Sci 1987;41:259-64.
33. Steardo L, Nathanson JA. Brain barrier tissues: end organ for atriopeptins. Science 1987;255:470-2.
34. Manning PT, Schawartz D, Katsube NC. Vasopressin stimulated release of atriopeptin: endocrine antagonists in fluid homeostasis. Science 1985;229:395-7.
35. Palkovits M, Geiger H, Bahner U. Atrial natriuretic factor in central nervous system regulatory mechanisms: effects of experimental alterations in water and salt homeostasis and blood pressure. Miner Electrolyte Metab 1990;16:42-7.
36. Brown J, Czarnecki A. Distribution of atrial natriuretic factor receptor subtypes in rat brain. Am J Physiol 1990;258:1078-85.
37. Lee J, Feng JQ. Centrally administered atrial natriuretic factor increases renal weater excretion. Am J Physiol 1987;252:1011-5.
38. Sarlius IH, Huxley VH. A direct effect of atrial nariuretic peptide on arterioles of the terminal microvasculature. Am J Physiol 1990;258:1224-9.
39. Lax D, Eicher M, Goldberg SJ. Effects of hydration on mitral valve prolapse. Am Heart J 1995;126:415-8.
40. Lee RW, Gay RG, Goldman S. Atrial natriuretic peptide reverses angiotensin-induced venocostriction in dogs. Am J Physiol 1989;257:1062-7.
41. Brehaus BA, Saneii HH, Brandtm.A. Atriopeptn II lowers cardiac output in conscious sheep. Am J Physiol 1985;249:776-80.
42. Chien YW, Frolich FD, Trippodo NC. Atrial natriuretic peptide increases resistance to venous return in rats. Am J Physiol 1987;252:852-8.
43. Holtz J, Stewart DJ, Elsner D. In vivo atrial peptide venodilatation : minimal potency relative to nitroglycerin in dogs. Life Sci 1986;59:2177-84.
44. Trippodo NC, Barbee RW. Atrial natriuretic factor decreases whole-body capillary absorption in rats. Am J Physiol 1987;252:915-20.
45. Trippodo NC, Cole FE, Frolich ED, McPhee AA. Atrial natriuretic peptide decreases circulatory capacitance in areflexic rats. Circ Res 1986;59;291-6.
46. Almeida FA, Suzuki M, Maack T. Atrial natriuretic factor increases hematocrit and decreases plasma volume in nephrectomized rats. Life Sci 1986;59:1195-9.
47. Fluckingeri R, Waeber S, Matsueda O, Delaloye B. Effect of atriopeptin III on hematocrit and volemia of nephrectomized rats. Am J Physiol 1986;251:880-5.
48. Hirata Y, Ishii M, Fukui K, Sugimoto T, Atarashi K, Matsuoka H, Lizuka M. The extrarenal effects of atrial natriuretic peptide on body fluid distribution. Am J Hypertension 1990;5:140-7.
49. Valentini P, Ribstein J, Mimran A. Effect of nicardipine and atriopeptin on transcapillary shift of fluid and proteins. Am J Physiol 1989;257:174-9.
50. Williamson JR, Holmberg SW, Chang K, Marvel J. Mechanisms underlying atriopeptin induced increases in hematocrit and vascular permeatin in rats. Circ Res 1989;64:890-9.
51. Petterson A, Jonssonc O. Effects of atrial natriuretic peptide (ANF) on jeurnal net fluid absorption in the rat. Acta Physiol Scand 1989;156:419-26.
52. Thamsborg G, Storm T, Keller N. Changes in plasma atrial natriuretic peptide during exercise in healty volunteers. Acta Med Scand 1987;221:441-4.
53. Donckier JE, De Coster PM, Cauwe FM. Effect of exercise on plasma atrial natriuretic factor and cardiac function in men and women. Eur J Clin Invest 1988;18:415-9.
54. Kanstrup IL, Hoilund-Carlsen PF, Gadsboll N. Atrial natriuretic factor; comparability of venous and arterial plasma measurements in man at rest and during exercise. Clin Sci 1989;77:519-22.
55. Hollister AS, Tanaka I, Imada T, Onrot J, Ingami T. Sodium loading and posture modulate human atrial natriuretic factor plasma levels. Hypertension 1986; 8(Suppl. 11):106-11.
56. Marks ES, Ohman KP, Reiser HR. Atrial natriuretic factor (ANF 105-126) enhances volume and pressor induced heart rate response in the conscious rat. Acta Physiol Scand 1990;158:161-5.
57. Atchison DJ, Ackermann U. Influence of atrial natriuretic factor on autonomic control of heart rate. Am J Physiol 1990;258:R718-25.
58. Rankin AJ. Mechanisms for the realease of natriuretic peptide. Am J Physiol Pharmacol 1986;65:1675-9.
59. Burnetti C. Atrial natriuretic factor secretion: Physiological regulation and implications in cardiovascular disease. Curr Opin Cardiol 1987;2:655-9.
60. Bilder GE, Blaine EH. Release of atrial natriretic factor, effects of repetitive stretch and temperature. Am J Physiol 1986;251:817-21.
61. Christensen G, Bugge JF, Ilebekk A. Atrial natriuretic peptide induces natriuresis during pacing tachycardia in dogs. Am J Physiol 1989;256:1245-9.
62. Miller W, Edwards BS, Zimmermann RS. Renal endocrin adaptations to endogenous atrial natriuretic factor during tachycardia induced reductions in renal perfusion pressure. Circ Res 1990;66:76-85.
63. Petterson A, Ricksten SE, Towles AC. Effect of blood volume expansion and sympathetic denervation on plasma levels of atrial natriuretic factor (ANF) in the rat. Acta Physiol Scand 1985;124:509-11.
64. Nishida Y, Miyata A, Morita H, Uemura N, Kaugawa K, Matsuo H et al. Lack of neural control of atrial natriuretic factor release in conscious dogs. Am J Physiol 1987;255:164-70.
65. Rankin AJ, Wilson N, Ledsome JR. Effects of autonomic stimulation on plasma immunoreactive atrial natriurelic factor in the anethstized rabbit. Can J Physiol Pharmacol 1986;65:552-7.
66. McGrath BP, Blake D, Jover B. :Atrial natriuretic peptide relesae in the rabbit is indipendent of cardiac nerve activity. Clin Exp Pharm Physiol 1987;14: 695-702.
67. Geer PG, Wang BC, Goetz KL. Effect of hemorrhage on plasma atriopeptin levels in conscious dogs. Proc Soc Exp Biol Med 1988;187:527-54.